MedGen Statistics

Total Valuation

MedGen has a market cap or net worth of 3,010.

Market Cap	3,010
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

MedGen has 3.01 billion shares outstanding.

Current Share Class	3.01B
Shares Outstanding	3.01B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.86
PB Ratio	-0.07
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.00

Current Ratio	0.00
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-1,199.01%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	36.27%
Weighted Average Cost of Capital (WACC)	-23.54%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.30
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	-39.85
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	0.00
Relative Strength Index (RSI)	46.76
Average Volume (20 Days)	1,286,991

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedGen had revenue of 1,051 and -15,539 in losses. Loss per share was -0.00.

Revenue	1,051
Gross Profit	1,051
Operating Income	-15,539
Pretax Income	-15,539
Net Income	-15,539
EBITDA	-15,374
EBIT	-15,539
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 110 in cash and 24,472 in debt, with a net cash position of -24,362 or -0.00 per share.

Cash & Cash Equivalents	110
Total Debt	24,472
Net Cash	-24,362
Net Cash Per Share	-0.00
Equity (Book Value)	-42,839
Book Value Per Share	-0.00
Working Capital	-43,516

Full Balance Sheet

Cash Flow

Operating Cash Flow	-14,390
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,478.50%
Pretax Margin	-1,478.50%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MedGen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-516.25%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 4, 2010. It was a reverse split with a ratio of 0.03333.

Last Split Date	Aug 4, 2010
Split Type	Reverse
Split Ratio	0.03333

Scores

MedGen has an Altman Z-Score of -244.55 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-244.55
Piotroski F-Score	1